Last reviewed · How we verify
64Cu-LLP2A
At a glance
| Generic name | 64Cu-LLP2A |
|---|---|
| Sponsor | Washington University School of Medicine |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- 64Cu-LLP2A CI brief — competitive landscape report
- 64Cu-LLP2A updates RSS · CI watch RSS
- Washington University School of Medicine portfolio CI